A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

Clinical trial NCT07287644 · RECRUITING

Trial details

NCT number: NCT07287644
Sponsor: Bluefin Biomedicine, Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)

Start date: 2025-11-03
Primary completion: 2027-08-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.